Article Information
History
- February 28, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Hannah Charles1,*,
- Katie Thorley1,
- Charlie Turner1,
- Kirsty F. Bennet1,
- Nick Andrews1,
- Marta Bertran1,
- Sema Mandal1,
- Gayatri Amirthalingam1,
- Mary E. Ramsay1,
- Hamish Mohammed1 and
- Katy Sinka1
- ↵*Corresponding author:
Hannah Charles, UK Health Security Agency, 61 Colindale Avenue, London, NW9 5EQ, UK; email: hannah.charles{at}ukhsa.gov.uk
Posted February 28, 2024.
Post-peak mpox in England: epidemiology, reinfection, and vaccine effectiveness – data from 2023
